Bath & Body Works, Inc. (NYSE:BBWI) Expected to Post Quarterly Sales of $1.43 Billion

Wall Street brokerages forecast that Bath & Body Works, Inc. (NYSE:BBWIGet Rating) will report $1.43 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for Bath & Body Works’ earnings, with the lowest sales estimate coming in at $1.42 billion and the highest estimate coming in at $1.44 billion. Bath & Body Works posted sales of $3.02 billion in the same quarter last year, which suggests a negative year over year growth rate of 52.6%. The company is expected to issue its next quarterly earnings results after the market closes on Monday, January 1st.

According to Zacks, analysts expect that Bath & Body Works will report full-year sales of $8.12 billion for the current fiscal year, with estimates ranging from $8.04 billion to $8.19 billion. For the next fiscal year, analysts forecast that the firm will report sales of $8.71 billion, with estimates ranging from $8.43 billion to $8.92 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover Bath & Body Works.

Bath & Body Works (NYSE:BBWIGet Rating) last announced its quarterly earnings data on Wednesday, February 23rd. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.03. Bath & Body Works had a negative return on equity of 115.32% and a net margin of 14.13%. The firm had revenue of $3.03 billion during the quarter, compared to analysts’ expectations of $2.96 billion. During the same period last year, the business posted $1.96 earnings per share. The company’s revenue for the quarter was up 11.4% compared to the same quarter last year.

Several research analysts have recently issued reports on BBWI shares. Morgan Stanley raised their price objective on Bath & Body Works from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, February 25th. Wells Fargo & Company reduced their price target on Bath & Body Works from $85.00 to $70.00 and set an “overweight” rating for the company in a research report on Tuesday, April 5th. Telsey Advisory Group reduced their price target on Bath & Body Works from $91.00 to $70.00 and set an “outperform” rating for the company in a research report on Thursday, February 24th. Cowen upgraded Bath & Body Works from a “market perform” rating to an “outperform” rating in a research report on Monday, May 2nd. Finally, MKM Partners reduced their price target on Bath & Body Works from $94.00 to $91.00 and set a “buy” rating for the company in a research report on Thursday, February 24th. Three research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $78.63.

In other news, CFO Wendy C. Arlin sold 6,000 shares of Bath & Body Works stock in a transaction that occurred on Tuesday, April 19th. The stock was sold at an average price of $55.00, for a total value of $330,000.00. Following the sale, the chief financial officer now directly owns 98,888 shares of the company’s stock, valued at $5,438,840. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.37% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company acquired a new position in Bath & Body Works during the third quarter worth $17,592,000. Gotham Asset Management LLC purchased a new stake in Bath & Body Works in the third quarter valued at $6,481,000. US Bancorp DE purchased a new stake in Bath & Body Works in the third quarter valued at $4,829,000. Citigroup Inc. purchased a new stake in Bath & Body Works in the third quarter valued at $13,581,000. Finally, Grantham Mayo Van Otterloo & Co. LLC purchased a new stake in Bath & Body Works in the third quarter valued at $3,664,000. 97.11% of the stock is currently owned by institutional investors.

Shares of NYSE:BBWI opened at $49.88 on Wednesday. Bath & Body Works has a 52-week low of $44.17 and a 52-week high of $82.00. The stock has a market cap of $11.90 billion, a price-to-earnings ratio of 10.14, a PEG ratio of 1.23 and a beta of 1.56. The business has a 50-day moving average price of $50.34 and a 200-day moving average price of $60.09.

About Bath & Body Works (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Further Reading

Get a free copy of the Zacks research report on Bath & Body Works (BBWI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.